A Next Generation Theranostic PSMA Ligand for 64Cu and 67Cu-Based Prostate Cancer Imaging and Therapy

被引：0
|
作者：
Ponnala, Shashikanth [7 ]
Amor-Coarasa, Alejandro [4 ]
Kelly, James [6 ]
Zia, Nicholas [1 ,2 ]
Clarence, Williams [7 ]
Nikolopoulou, Anastasia [7 ]
Donnelly, Paul [3 ]
Babich, John [5 ]
机构：
[1] Univ Melbourne, Sch Chem, Melbourne, Vic, Australia
[2] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Weill Cornell Med Coll, Bronx, NY USA
[5] Weill Cornell Med Coll, New York, NY USA
[6] Weill Cornell Med, New York, NY USA
[7] Weill Cornell Med, Radiol, New York, NY USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1005
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A stronger chelation for a superior theranostic : the preclinical study of 64Cu-DOTHA2-PSMA in prostate cancer animal model
    Milot, Marie-Christine
    Benesty, Ophelie Belissant
    Dumulon-Perreault, Veronique
    Ait-Mohand, Samia
    Rousseau, Etienne
    Richard, Patrick
    Guerin, Brigitte
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [42] 64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window
    Milot, Marie-Christine
    Benesty, Ophelie Belissant
    Dumulon-Perreault, Veronique
    Ait-Mohand, Samia
    Richard, Patrick O.
    Rousseau, Etienne
    Guerin, Brigitte
    PHARMACEUTICALS, 2022, 15 (08)
  • [43] In vivo evaluation of 64Cu radiolabeled gold nanocages for cancer PET imaging
    Luehmann, Hannah
    Wang, Yucai
    Xia, Xiaohu
    Brown, Paige
    Jarreau, Chad
    Welch, Michael
    Xia, Younan
    Liu, Yongjian
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [44] Application of Cu-64 NODAGA-PSMA PET in Prostate Cancer
    Sabina Sevcenco
    Hans Christoph Klingler
    Klaus Eredics
    Alexander Friedl
    Jenifer Schneeweiss
    Peter Knoll
    Thomas Kunit
    Lukas Lusuardi
    Siroos Mirzaei
    Advances in Therapy, 2018, 35 : 779 - 784
  • [45] Application of Cu-64 NODAGA-PSMA PET in Prostate Cancer
    Sevcenco, Sabina
    Klingler, Hans Christoph
    Eredics, Klaus
    Friedl, Alexander
    Schneeweiss, Jenifer
    Knoll, Peter
    Kunit, Thomas
    Lusuardi, Lukas
    Mirzaei, Siroos
    ADVANCES IN THERAPY, 2018, 35 (06) : 779 - 784
  • [46] 64Cu Radiolabeled PDGFRβ-Targeting Affibody for PET Imaging in Pancreatic Cancer
    Li, Zhao
    Geng, Ruiman
    Zhan, Yousheng
    Liu, Ruomeng
    Li, Mufeng
    Ke, Nengwen
    Yang, Hao
    Lu, Xiaofeng
    Li, Lin
    Li, Suping
    Cai, Huawei
    MOLECULAR PHARMACEUTICS, 2025, 22 (03) : 1633 - 1640
  • [47] Development of [64Cu]Cu-Albumin-Glutamate-Urea-Lysine/Fluorescence Complex as an Image-Guided Surgery Agent for PSMA-Expressing Prostate Cancer
    Chung, Y.
    Kim, J.
    Kim, J.
    Shin, Y.
    Suh, M.
    Park, J.
    Yoo, R.
    Lee, Y.
    Lee, K.
    Lee, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S445 - S446
  • [48] Preclinical evaluation and frst in human study of 64Cu-PSMA-3Q for prostate cancer imaging
    Zhang, Jingfeng
    Xu, Baixuan
    Zhang, Jinming
    Zhang, Xiaojun
    Liu, Yachao
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [49] Comparison of 68Ga-PSMA and 64Cu-PSMA in Patients with Recurrent Prostate Cancer
    Villano, C.
    Sindona, E.
    Pigotti, G.
    Ferrari, C.
    Cascini, G.
    Bruno, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S542 - S542
  • [50] Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for 64Cu-Based PET Imaging
    Umbricht, Christoph A.
    Benesova, Martina
    Hasler, Roger
    Schibli, Roger
    van der Meulen, Nicholas P.
    Mueller, Cristina
    MOLECULAR PHARMACEUTICS, 2018, 15 (12) : 5556 - 5564
12345